What is DiA Imaging Analysis?
DiA Imaging Analysis is at the forefront of transforming medical imaging through artificial intelligence. Founded in 2009 and based in Southern District, Israel, the company develops AI-based technology designed to enhance the accuracy and accessibility of ultrasound image analysis. Their innovative solutions empower clinicians by making the capture and interpretation of ultrasound images smarter, thereby improving diagnostic capabilities across a wide range of medical applications. The company's focus on integrating AI into the core of ultrasound diagnostics positions it as a key player in the rapidly evolving field of digital health.
How much funding has DiA Imaging Analysis raised?
DiA Imaging Analysis has raised a total of $19M across 2 funding rounds:
Unspecified
$5M
Series B
$14M
Unspecified (2018): $5M with participation from Israel Innovation Authority, DEFTA Partners, and Connecticut Innovations
Series B (2021): $14M led by Mindset Ventures, CE Ventures, Downing Ventures, XTX Ventures, Dr Shmuel Cabilly, Icon Advisers, Connecticut Innovations, DEFTA Partners, Alchimia Ventures, and Philips
Key Investors in DiA Imaging Analysis
DEFTA Partners
DEFTA Partners is a global venture investment firm specializing in innovative technologies within healthcare and information and communication technology, with a strategic focus on enhancing healthcare through advanced therapeutics and health ICT.
Connecticut Innovations
Connecticut Innovations serves as the state's strategic venture capital arm, providing crucial equity and debt financing, alongside strategic guidance, to help innovative companies scale, with dedicated funds for sectors like AI/quantum, climate tech, and biosciences.
Philips
Philips is a diversified health and well-being company focused on improving lives through innovation in Healthcare, Consumer Lifestyle, and Lighting, delivering products and services across more than 100 countries worldwide.
What's next for DiA Imaging Analysis?
With its latest major strategic investment, DiA Imaging Analysis is poised for accelerated growth and further innovation. The substantial backing suggests a strong market validation and provides the resources necessary to scale operations, expand its technological capabilities, and broaden its market reach. Future developments are likely to focus on enhancing its AI algorithms, securing regulatory approvals in new markets, and forging strategic partnerships within the healthcare ecosystem to integrate its solutions more deeply into clinical workflows. This capital infusion is expected to solidify DiA Imaging Analysis's position as a leader in AI-powered medical imaging.
See full DiA Imaging Analysis company page
